Single maintenance and reliever therapy (SMART) of asthma

Thorax

Volumn 66, Issue 1, 2011, Pages 86-87

  Reddel, Helen K ^a   Yan, Kwok Y ^b  

^a WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; DEVICE; DISEASE CONTROL; DISEASE EXACERBATION; LETTER; MAINTENANCE THERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SINGLE MAINTENANCE AND RELIEVER THERAPY; VALIDITY;

EID: 78650198691     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.149773     Document Type: Letter

References (5)

1. Chapman KR, Barnes NC, Greening AP, et al. Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal. Thorax 2010;65:747-52.
2. Bateman ED, Reddel HK, Eriksson G, et al. Overall asthma control: the relationship between current control and future risk. J Allergy Clin Immunol 2010;125:600-8.
3. Kuna P, Peters MJ, Manjra AI, et al. Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract 2007;61:725-36.
4. Cates CJ, Lasserson TJ. Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children. Cochrane Database Syst Rev 2009;(2):CD007313.
5. Cates CJ, Lasserson TJ. Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children. Cochrane Database Syst Rev 2009;(2):CD007085.